Claudia Lasagni
Claudia Lasagni
Dermatologia Azienda Ospedaliero Universitaria Policlinico di Modena
Email verificata su policlinico.mo.it
Titolo
Citata da
Citata da
Anno
Echographic assessment of age‐dependent variations of skin thickness: A study on 162 subjects
C Lasagni, S Seidenari
Skin Research and Technology 1 (2), 81-85, 1995
591995
Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: a multicentric retrospective analysis
V Di Lernia, L Stingeni, V Boccaletti, PG Calzavara Pinton, C Guarneri, ...
Journal of Dermatological Treatment 27 (5), 395-398, 2016
382016
Evolution of COVID‐19 infection in four psoriatic patients treated with biological drugs
A Conti, C Lasagni, L Bigi, G Pellacani
Journal of the European Academy of Dermatology and Venereology 34 (8), e360-e361, 2020
252020
Effectiveness and safety of acitretin in children with plaque psoriasis: a multicenter retrospective analysis
V Di Lernia, D Bonamonte, C Lasagni, A Belloni Fortina, S Cambiaghi, ...
Pediatric dermatology 33 (5), 530-535, 2016
252016
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry
P Gisondi, S Cazzaniga, S Chimenti, M Maccarone, M Picardo, ...
British Journal of Dermatology 172 (6), 1613-1620, 2015
232015
Management of patients with psoriasis treated with biological drugs needing a surgical treatment
A Fabiano, C De Simone, P Gisondi, S Piaserico, C Lasagni, G Pellacani, ...
Drug development research 75, S24-S26, 2014
202014
Management of long‐term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting
A Conti, S Piaserico, P Gisondi, G Odorici, G Galdo, C Lasagni, ...
Dermatologic therapy 30 (5), e12503, 2017
102017
Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis.
GIDIDE VENEREOLOGIA
G Ital Dermatol Venereol, 2016
92016
Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-centre experience
G Odorici, V Di Lernia, F Bardazzi, M Magnano, S Di Nuzzo, C Cortelazzi, ...
Journal of the European Academy of Dermatology and Venereology: JEADV 33 (10 …, 2019
82019
Pruritus characteristics in a large Italian cohort of psoriatic patients
G Damiani, S Cazzaniga, RR Conic, L Naldi, Psocare Registry Network, ...
Journal of the European Academy of Dermatology and Venereology 33 (7), 1316-1324, 2019
82019
Monoclonal gammopathy of undetermined significance in patients with psoriasis: is it really a side effect of biological therapy?
A Conti, I Esposito, C Lasagni, R Miglietta, C Padalino, A Fabiano, ...
Drug development research 75, S35-S37, 2014
82014
Acute maculopapular eruption in Covid-19 patient: A case report
E Rossi, C Lasagni, M Trakatelli, S Wertzberger Rowan, C Magnoni
62020
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning.
P Gisondi, P Amerio, GF Amoroso, VA Antonucci, F Bardazzi, ...
Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa …, 2013
62013
Adalimumab in severe plaque psoriasis of childhood: A multi‐center, retrospective real‐life study up to 52 weeks observation
V Di Lernia, L Bianchi, C Guerriero, L Stingeni, P Gisondi, A Filoni, ...
Dermatologic therapy 32 (6), e13091, 2019
52019
Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies
C Lasagni, L Bigi, A Conti, G Pellacani
Journal of Dermatological Treatment 29 (sup2), 5-8, 2018
52018
TNFα blockers and psoriasis: a'reasonable paradox'-the role of TH-17 cells.
A Sartini, M Di Girolamo, A Scarcelli, A Bertani, L Marzi, C Lasagni, ...
Alimentary pharmacology & therapeutics 39 (10), 1244-1246, 2014
32014
A real‐life experience of psoriatic patients with history of cancer treated with biological drugs
G Odorici, C Lasagni, L Bigi, G Pellacani, A Conti
Journal of the European Academy of Dermatology and Venereology 33 (12), e453 …, 2019
22019
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: a Northern Italy experience
P Gisondi, S Piaserico, L Naldi, P Dapavo, A Conti, P Malagoli, ...
Journal of allergy and clinical immunology, 2020
12020
Chronic kidney disease in psoriasis: a cohort study
A Conti, L Giovannini, VD Mandel, G Odorici, C Lasagni, L Bigi, ...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (5), 438-445, 2020
12020
The wild market of natural cosmetics of obscure safety
MM Lauriola, M Corazza
Dermatology 235 (6), 527-528, 2019
12019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20